Zusammenfassung
Die nichtinvasive Kontrolle einer antiarrhythmischen Therapie wird anhand der Reduktion spontaner Arrhythmien im Langzeit-EKG durchgeführt. Probleme dieses Verfahrens liegen unter anderem in der ausgeprägten Spontanvariabilität der ventrikulären Arrhythmien und vor allem in dem fehlenden Nachweis, daß eine Reduktion dieser Ektopien den plötzlichen Herztod verhindert. Es wäre also von großem klinischen Nutzen, über eine weitere nichtinvasive Methode zur Einschätzung der Wirkung von Antiarrhythmika zu verfügen. Dabei bietet sich das Signalmittelungs-EKG an, da es mit der Beschreibung von Spätpotentialen den Nachweis von Zonen verzögerter Erregung ermöglicht, die eine Basis für kreisende Tachykardien darstellen können (9, 15, 16, 17, 35). Diese im Signalmittelungs-EKG erfaßbaren Spätpotentiale sind elektrische Signale, die nach Beendigung der normalen Kammererregung, also am Ende des QRS-Komplexes und in der folgenden ST-Strecke auftreten (2, 8, 35, 36), (Abb. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abboud S, Beihassen B, Landiado S, Sadeh D (1983) Noninvasive recording of late ventricular activity using an advanced method in patients with a damaged mass of ventricular tissue. J Electrocardiol 16: 245
Berbari EJ, Lazzara R (1988) An introduction to high-resolution ECG recordings of cardiac late potentials. Arch Int Med 148: 1859
Boineau JP, Cox JL (1973) Slow ventricular activation in acute myocardial infarction. A source of reentrant premature ventricular contractions. Circulation 48: 702
Borbola J, Denes P (1988) Oral Amiodarone loading therapy. I The effect on serial signal-averaged elecrocardiographic recordings and the OTc in patients with ventricular tachyarrhythmias. Am Heart J 115: 1202
Borggrefe M, Karbenn U, Breithardt G (1982) Spätpotentiale und elektrophysiologische Befunde bei ventrikulären Tachykardien. Z Kardiol 71: 627
Breithardt G, Borggrefe M, Karbenn U, Schwarzmaier J (1988) Effects of pharmacological and non-pharmacological interventions on ventricular late potentials. Eur Heart J 8 (Suppl A): 97
Breithart G, Schwarzmaier J, Borggrefe M, Haerten K, Seipel L (1983) Prognostic significance of later ventricular potentials after acute myocardial infarction. Eur Heart J 4: 487
Breithart G, Schwarzmaier J, Karbenn U, Yeh HL, Seipel L (1982) Klinische Bedeutung nichtinvasiv registrierter ventrikulärer Spätpotentiale. Dtsch Med Wschr 107: 643
Breithart G, Borggrefe M (1991) Pathophysiological mechanisms and clinical significance of ventricular late potentials, in press
Buckingham TA, Thessen CM, Hertweck D, Janosik DL, Kennedy HL (1989) Signal-averaged electrocardiography in the time and frequency domains. Am J Cardiol 63: 820
Cain ME, Ambos HD, Fischer AE, Markham J, Schechtman KB (1984) Non-invasive prediction of antiarrhythmic drug efficacy in patients with sustained ventricular tachycardia from frequency analysis of signal averaged ECGs. Circulation 70 (Suppl II): 252
Cain ME, Ambos HD, Witkowski FX, Sobel BE (1984) Fast-Fourier transform analysis of signalaveraged electrocardiograms for identification of patients prone to sustained ventricular tachycardia. Circulation 69: 711
De Langen CDJ, Spear JF, Levine JH, Moore EN (1985) The effect of procainamide on body surface late potentials and epicardial activation in infarcted dogs. Circulation 72 (Suppl III): 225
Denniss AR, Ross DL, Cody DV, Ho B, Russell PA, Young AA (1984) Effect of antiarrhythmic therapy on delayed potentials in patients with ventricular tachycardia. JACC 3: 495
El-Sherif N, Turitto G, Fontaine JM (1988) Risk stratification of patients with complex ventricular arrhythmias. Herz 13: 204
El-Sherif N, Gomes JA, Restivo M, Mehra R (1985) Late potentials and arrhythmogenesis. Pace 8, 440
El-Sherif N, Mehry R, Gomes JAC, Kelen G (1983) Appraisal of a low noise electrocardiogram, J Am Coll Cardiol 1: 456
Fauchier JP, Cosnay P, Moquet B, Balleh H, Rouesnel PH (1988) Late ventricular potentials and spontaneous and induced entricular arrhythmias in dilated or hypertrophic cardiomyopathies. A prospective study about 83 patients. Pace 11: 1974
Fenoglio JJ, Albala A, Silva FG, Friedmann PL, Wit AL (1976) Structural basis of ventricular arrhythmias in human myocardial infarction: a hypothesis. Hum-Pathol 7: 547
Gallagher JD, Fernandez J, Maranhao V, Gessman LJ (1986) Simultaneous Appearance of Endocardial Late Potentials and Ability to Induce Sustained Ventricular Tachycardia After Procainamide Administration. J Electrocard 19: 197–202
Gessman L, Gallagher J, Del Rossi A, Fernandez J, Strong M, Maranhao V (1983) Prolongation of late potentials by type I antiarrhythmic drugs coincident with inducibility of ventricular tachycardia. Circulation 68 (Suppl III): 173
Goedel-Meinen L, Hofmann M, Schmidt G, Maier-Rudolph W, Barthel P, Schrag A, Baedeker W, Blömer H (1990) Amiodarone and late potentials during long-term therapy. Clin Pharmacol Ther Tox 28: 449
Goedel-Meinen L, Schmidt G, Hofmann M, Jahns G, Klein G, Baedeker W, Blömer H (1986) Spätpotentiale vor und während akuter Testung von Klasse-I-Antiarrhythmika. Z Kardiol 75 (Suppl 4): 45
Haberl R, Jilge G, Pulter R, Steinbeck G (1988) Comparison of frequency and time domain analysis of the signal-averaged electrocardiogram in patients with ventricular tachycardia and coronary heart disease: methodologic validation and clinical relevance. JACC 12: 150
Hombach V, Höpp HW, Braun V, Behrenbeck DW, Tauchert M, Hilger HH (1980) Die Bedeutung von Nachpotentialen innerhalb des ST-Segments im Oberflächen-EKG bei Patienten mit koronarer Herzkrankheit. Dtsch Med Wschr 105: 145
Höpp HW, Deutsch H, Hombach V, Braun V, Hilger HH (1982) Medikamentöse Beeinflußbarkeit ventrikulärer Spätpotentiale. Z Kardiol 71: 206
Jauernig RA, Senges J, Lengfelder W, Rizos I, Hoffmann E, Brachmann J, Kübler W (1983) Effect of antiarrhythmic drugs on ventricular late potentials at sinus rhythm and at constant heart rate. In: Steinbach K, Glogar D, Laszkovics A, Scheiblhofer W, Weber H (eds) Cardiac Pacing. Steinkopff, Darmstadt, pp 773–778
Kidwell GA, Greenspon AJ, Decaro M, Volosin KJ, Jefferies L (1987) Use of the signalaveraged electrocardiogram to predict antiarrhythmic drug effect on sustained ventricular tachycardia. Circulation 76 (Suppl IV): 344
Naito M, Michelson EL, Kmetzo JJ, Kaplinsky E, Dreifus LS (1981) Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy. J Pharmacol exper Ther 218, 475–480
Oeff M (1987) Einzelschlagregistrierung verspäteter ventrikulärer Depolarisationen und ihre Frequenzanalyse mit der Fast-Fourier-Transformation. Methodische Aspekte. In: Steinbeck G (ed) Lebensbedrohliche ventrikuläre Herzrhythmusstörungen. Fortschritte in Diagnostik und Therapie. Steinkopff, Darmstadt, S 129
Patterson E, Gibson JK, Lucchesi BR (1982) Electrophysiologic actions of lidocaine in an canine model of chronic myocardial ischemic damage — arrhythmogenic actions of lidocaine. J Cardiovasc Pharm 4, 924–934
Rozanski JJ, Mortara D, Myerburg RJ, Castellanos A (1981) Body surface detection of delayed depolarizations in patients with recurrent ventricular tachycardia and left ventricular aneurysm. Circulation 63: 1172
Simson MB, Falcone R, Kindwall E (1985) The signal averaged electrocardiogram does not predict antiarrhythmic drug success. Circulation 72 (Suppl III): 7
Simson MB, Waxman HL, Falcone R, Marcus NH, Josephson ME (1983) Wirkungen von Antiarrhythmika auf nichtinvasiv registrierte Spätpotentiale. In: Breithardt, Loogen (Hrsg) Neue Aspekte in der medikamentösen Behandlung von Tachyarrhythmien (Die Bedeutung von Amiodaron). Urban und Schwarzenberg, München, S 86–93
Simson MB, Euler D, Michelson EL, Falcone RA, Spear JF, Moore NE (1981) Detection of delayed ventricular activation on the body surface in dogs. Am Physiol 241: 363
Simson MB (1981) Use of signals in the terminal QRS-complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation 64: 235
Steinberg JS, Freedman RA (1987) The signal averaged ECG does not predict drug efficacy in sustained ventricular arrhythmias. Circulation 76 (Suppl IV): 344
Vaughan-Williams EM (1970) Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Oelsen KH, Astra ABJ (eds) Symposion on Cardiac Arrhythmias. Södertälje, Sweden, pp 449–472
Zipes DP, Elharrar V, Noble RJ, Gaum WE, Troup PJ, Fasola A (1977) Effects of various drugs on ventricular conduction delay and ventricular arrhythmias during myocardial ischaemia in the dog. In: HE Kulbertus, Re-entrant Arrhythmias. Mechanisms and Treatment. Lancaster, pp 312–326
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Goedel-Meinen, L., Hofmann, M., Schmidt, G., Barthel, P., Baedeker, W., Blömer, H. (1991). Ist das signalgemittelte EKG zur Kontrolle einer antiarrhythmischen Therapie geeignet?. In: Schmidt, G. (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST. Steinkopff. https://doi.org/10.1007/978-3-642-85414-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-85414-9_8
Publisher Name: Steinkopff
Print ISBN: 978-3-642-85415-6
Online ISBN: 978-3-642-85414-9
eBook Packages: Springer Book Archive